Holdings (44)
| Name | Sector | Instrument | Assets |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 7.99% |
| Abbott India Ltd | Healthcare | Equity | 5.94% |
| Healthcare Global Enterprises Ltd | Healthcare | Equity | 5.92% |
| Divi's Laboratories Ltd | Healthcare | Equity | 5.68% |
| Dr. Reddy's Laboratories Ltd | Healthcare | Equity | 4.65% |
| Apollo Hospitals Enterprise Ltd | Healthcare | Equity | 4.36% |
| Rainbow Childrens Medicare Ltd | Healthcare | Equity | 4.3% |
| Cipla Ltd | Healthcare | Equity | 4.22% |
| Torrent Pharmaceuticals Ltd | Healthcare | Equity | 3.76% |
| Max Healthcare Institute Ltd | Healthcare | Equity | 3.71% |
Returns and rankings
| 1Y | 3Y | 5Y | All | |
|---|---|---|---|---|
| Fund Returns | 10.87% | 19.18% | 15.93% | 9.22% |
| Category Average | -2.14% | 22.11% | 14.61% | NA% |
| Rank Within Category | 21.00% | 11.00% | 6.00% | NA% |
Expense ratio, exit load and tax
Expense ratio: 1.09%
Inclusive of GST
Exit load
Exit load of 0.25% if redeemed within 30 days.
Stamp duty
0.005% (from July 1st, 2020)
Tax implication
If you redeem within one year, returns are taxed at 20%. If you redeem after one year, returns exceeding Rs 1.25 lakh in a financial year are taxed at 12.5%.
Fund management
Education
Mr. Srivastava has done BBA (Banking & Insurance), PGDM - IMT Ghaziabad
Experience
Prior to joining Tata Mutual Fund, he has worked with Incred Asset Management, Kotak Investment Banking, Emkay Global, Evalueserve and Motilal Oswal Financial Services